Icon

TRIESENCE (nda022048)- (40MG/ML (40MG/ML))

TRIAMCINOLONE ACETONIDE HARROW EYE
40MG/ML (40MG/ML)
No Yes
2029-Dec-17 Expired
None 2010-Nov-29
None No
TRIESENCE™ is a synthetic corticosteroid indicated for: • Treatment of the following ophthalmic diseases: sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids. • Visualization during vitrectomy.
0 0 0
Total Other Developers None
Drugs with Suitability No
40MG/ML (40MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.